MENU

Fox Chase Cancer Center News

Reimann Research Building
January 2, 2020

Fox Chase Cancer Center Junior Investigators Win Awards for Pilot Projects

PHILADELPHIA (January 2, 2020) – The purpose of the Institutional Research Grant is to provide seed money for the initiation of promising new projects by newer investigators so they can obtain preliminary results that will enable them to compete successfully for national research grants. The Special Interest Award provides support for psychosocial and behavioral research, health policy or health services research, cancer in the poor and medically underserved, and childhood cancer.

January 2, 2020

Fox Chase Cancer Center Welcomes Sheela Ahmed

PHILADELPHIA (January 2, 2020) – Dr. Ahmed will be joining the Department of Medicine as an associate clinical professor in the Division of Pulmonary, Sleep, and Critical Care Medicine on January 6, 2020.

December 30, 2019

Fox Chase Cancer Center Welcomes Usman Ali

Usman Ali, MD, will begin as a hospitalist at Fox Chase on January 6, 2020.

Dylan Sherry, MD
December 30, 2019

Fox Chase Cancer Center Welcomes Dylan R. Sherry

Dr. Sherry will be joining the Pain and Palliative Care Program in the Department of Hematology/Oncology as an assistant professor.

December 20, 2019

Fox Chase-Temple Bone Marrow Transplant Program Recognized for Excellence

PHILADELPHIA (December 20, 2019) – The Fox Chase-Temple University Hospital Bone Marrow Transplant Program has been recognized by the CIBMTR for performing better than expected for successful transplant procedures. Fox Chase was the only adult treatment center in the tristate area to achieve this distinction.

December 18, 2019

Temple and Jefferson Sign Definitive Agreement For Sale of Fox Chase Cancer Center to Jefferson and to Create Broad Affiliation

PHILADELPHIA (Dec. 18, 2019)—Temple University and Thomas Jefferson University today announced that the two institutions have entered into a binding Definitive Agreement for the acquisition by Jefferson of Fox Chase Cancer Center (FCCC), as well as Temple’s Bone Marrow Transplant program.

Dr. Plimack will begin her four-year term in June 2020.
December 17, 2019

Fox Chase Physician Elizabeth Plimack Elected to Board of American Society of Clinical Oncology

PHILADELPHIA (December 17, 2019) – Elizabeth Plimack, MD, MS, professor and chief of the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center, will begin her four-year term in June 2020 and is eager to be representing Fox Chase as she works to encourage collaboration and methods of sharing information in oncology.

 “We showed that the DNA we treated was expressed in the liver and could reverse the phenotypes we observed in mice with CBS deficiency.”
December 16, 2019

Gene Therapy a Possible Treatment for Metabolic Condition in Children

PHILADELPHIA (December 16, 2019) – New research from Fox Chase Cancer Center has set the framework for gene therapy as a possible treatment for human cystathionine beta-synthase deficiency, the most common inborn error of metabolism found in children. “We showed that the DNA we treated was expressed in the liver and could reverse the phenotypes we observed in mice with CBS deficiency.”

Pages

Connect with Fox Chase